Article Details
Retrieved on: 2021-02-03 11:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
People living in the UK with severe atopic dermatitis are to be given early access to Pfizer's abrocitinib following a green light by the Medicines and ...
Article found on: www.pharmatimes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here